Cow's-milk-protein-free diet versus omeprazole for reflux in infants
Official title: Treatment of Gastroesophageal Reflux Disease in Infants- a Randomized Controlled Trial
Run by Odense University Hospital · NCT06255886 · Data updated 2026-11-12
This test compares a cow's-milk-protein-free diet to the medicine omeprazole for infants under one year who have troublesome gastroesophageal reflux.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 1 Month to 1 Year |
| Sex | All |
| Enrollment | 96 (estimated) |
| Sponsor | Odense University Hospital Academic / other |
| Locations | 3 sites (Aabenraa, Region Syddanmark and 2 other locations) |
| Status | Recruiting |
| Started | October 27, 2025 |
| Main results expected | December 26, 2026 |
| Study ends | December 26, 2026 |
| Registry record updated | November 20, 2025 |
| Trial ID | NCT06255886 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Infants aged 1 to 11 months with diagnosed gastroesophageal reflux disease who have at least three reflux episodes per day and troublesome symptoms are ideal candidates.
✕Probably not a fit
Infants with known cow's milk protein allergy, recent PPI treatment, major congenital or metabolic disorders, or those already on a cow's-milk-free diet may not benefit from enrollment.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Infants under one year with gastroesophageal reflux disease are assigned to a cow's-milk-protein-free diet, omeprazole treatment, or placebo, with symptoms and feeding/weight outcomes tracked during the treatment period. Inclusion requires at least three reflux episodes per day and presence of troublesome symptoms such as unexplained crying, poor weight gain, or back-arching. Exclusions include recent PPI use, diagnosed cow's milk protein allergy, certain congenital or metabolic conditions, and infants already on a cow's-milk-free diet. The trial compares symptom change, adverse events, and growth to see which approach reduces troublesome reflux while minimizing side effects.
Why it matters
Potential benefit: If successful, this could reduce unnecessary PPI use and offer a safer dietary option that lowers symptoms and side effects in infants with GERD.
How similar studies have gone: Previous randomized studies in infants under one year are few and generally have not shown clear symptom benefit from PPIs, and recommendations for cow's-milk-protein-free diets are based on weak evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Infants diagnosed with gastroesophageal reflux disease (GERD) * Age \< 1 year at the time of referral * Age \>1 month at start of treatment * At least 3 reflux episodes/daily in average * At least one of following troublesome symptoms are present: Crying of unknown reason, discomfort/irritability, problems gaining weight/ weightloss, rejects the breast or bottle, apnea, back-arching. Exclusion Criteria: * Children with diagnosed or suspected syndrome /genetic disorder * Congenital malformations (minor deformities are excepted) * Abdominal surgery * Metabolic disease * Treatment with proton pump inhibitor within the last week * Allergy for proton pump inhibitors * Allergy for cow milk protein * Infants on Cow's milk free diet
Where it's running
-
Paediatric Department, Hospital of Southern Jutland
Aabenraa, Region Syddanmark, Denmark Recruiting -
Børnelægecentret v/Kasper Dalby
Odense, Region Syddanmark, Denmark Not yet recruiting -
H.C Andersen Childrens' Hospital
Odense, Region Syddanmark, Denmark Not yet recruiting
Study contacts
- Study coordinator: Natalia K Barkholt, MD
- Email: Natalia.Barkholt@rsyd.dk
- Phone: +4521787136
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
POEM vs Heller myotomy with Dor fundoplication for achalasia
This trial tests POEM against laparoscopic Heller myotomy with Dor fundoplication to see which procedure better helps adults with achalasia.
-
Hydrotalcite (Talcid) for relief of rebound acid symptoms after stopping long-term PPI therapy
We are trying hydrotalcite (Talcid) to see if it relieves rebound acid symptoms in adults who have stopped long-term PPI treatment.
-
Evaluating chest physiotherapy for infants with bronchiolitis
This study tests if chest physiotherapy given by mothers can help infants under 12 months with bronchiolitis feel better compared to just standard hospital care.
-
Monitoring vital signs of newborns using advanced wireless sensors
This study is testing a new wireless sensor to see if it can safely and accurately monitor the vital signs of healthy newborns during their first two hours after birth compared to the traditional wired system.
-
Detecting Barrett's Esophagus in Patients Without GERD Symptoms
This study is testing a new way to find Barrett's esophagus in people who don’t have GERD symptoms by using a simple capsule test instead of the usual endoscopy.
-
Testing platelet transfusion thresholds in extremely preterm infants
This study is testing if giving platelet transfusions at a lower level can help extremely premature babies survive without major bleeding during their first week of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.